Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 9
Market value 9
Market Segmentation 10
Geography segmentation 10
Market share 11
Market Outlook 12
Market value forecast 12
Five Forces Analysis 13
Summary 13
Buyer power 14
Supplier power 16
New entrants 17
Threat of substitutes 19
Degree of rivalry 20
Leading Companies 22
Chiesi Farmaceutici SpA 22
Pfizer Inc. 24
Recordati S.p.A. 28
The Menarini Group 31
Macroeconomic Indicators 32
Country data 32
Methodology 34
Industry associations 35
Related MarketLine research 35
Appendix 36
About MarketLine 36

List of Tables
Table 1: Italy pharmaceuticals market value: $ billion, 2013-17
Table 2: Italy pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: Italy pharmaceuticals market share: % share, by value, 2017
Table 4: Italy pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Chiesi Farmaceutici SpA: key facts
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: key financials ($)
Table 8: Pfizer Inc.: key financial ratios
Table 9: Recordati S.p.A.: key facts
Table 10: Recordati S.p.A.: key financials ($)
Table 11: Recordati S.p.A.: key financials (€)
Table 12: Recordati S.p.A.: key financial ratios
Table 13: The Menarini Group: key facts
Table 14: Italy size of population (million), 2013-17
Table 15: Italy gdp (constant 2005 prices, $ billion), 2013-17
Table 16: Italy gdp (current prices, $ billion), 2013-17
Table 17: Italy inflation, 2013-17
Table 18: Italy consumer price index (absolute), 2013-17
Table 19: Italy exchange rate, 2013-17

List of Figures
Figure 1: Italy pharmaceuticals market value: $ billion, 2013-17
Figure 2: Italy pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: Italy pharmaceuticals market share: % share, by value, 2017
Figure 4: Italy pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in Italy, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in Italy, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in Italy, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2017
Figure 11: Pfizer Inc.: revenues & profitability
Figure 12: Pfizer Inc.: assets & liabilities
Figure 13: Recordati S.p.A.: revenues & profitability
Figure 14: Recordati S.p.A.: assets & liabilities